OSCR
Oscar Health, Inc.
OSCR has the edge over QTRX overall, supported by stronger fundamentals and lower modeled downside.
QTRX
Quanterix Corporation
QTRX offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
QTRX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Unavailable |
QTRX's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
QTRX PE Valuation
QTRX has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
OSCR has the edge over QTRX on the outlook, with more favorable revenue expectations.
QTRX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect QTRX's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over QTRX on earnings quality, reporting a profit while its opponent remains loss making.
QTRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.35 | -$0.02 |
| Q2 2026 | -$2.62 | -$0.80 |
| Q1 2026 | -$2.35 | -$1.11 |
| Q4 2025 | -$2.51 | -$1.51 |
| Q3 2025 | -$2.33 | -$1.40 |
| Q2 2025 | -$1.82 | -$0.90 |
| Q1 2025 | -$1.24 | -$0.35 |
| Q4 2024 | -$1.00 | -$0.24 |
QTRX lost $2.35 per share over the past year, about the same as its loss the year before.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over QTRX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over QTRX on profitability, with a higher operating margin.
QTRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35M | -13% |
| Q2 2026 | $32.9M | +34% |
| Q1 2026 | $36.4M | +20% |
| Q4 2025 | $43.9M | +25% |
| Q3 2025 | $40.2M | +12% |
| Q2 2025 | $24.5M | -29% |
| Q1 2025 | $30.3M | -5.4% |
| Q4 2024 | $35.2M | +11% |
QTRX's revenue is growing: $35M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -64% | +29 points |
| Q2 2026 | -150% | +1.4 points |
| Q1 2026 | -114% | -27 points |
| Q4 2025 | -56% | -14 points |
| Q3 2025 | -93% | -60 points |
| Q2 2025 | -152% | -120 points |
| Q1 2025 | -87% | -40 points |
| Q4 2024 | -42% | +1.2 points |
QTRX's operating margin was −64% last quarter, up 28 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over QTRX on cash generation, producing positive trailing cash flow while its opponent burns cash.
QTRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.3M | +$25.6M |
| Q2 2026 | -$5.2M | +$1.2M |
| Q1 2026 | -$18.2M | -$3.1M |
| Q4 2025 | -$16.3M | -$11.6M |
| Q3 2025 | -$41.9M | -$35.3M |
| Q2 2025 | -$6.4M | +$118K |
| Q1 2025 | -$15.1M | +$5.5M |
| Q4 2024 | -$4.7M | +$3.4M |
QTRX has burned cash in almost every quarter: −$56M over the past year, against −$68M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
QTRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +221K shares |
| 1 year | +2.9% | +1.3M shares |
| 3 years | +26% | +9.7M shares |
| 5 years | +30% | +10.9M shares |
| Available history | +69% | +19.4M shares |
QTRX has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
QTRX Net Leverage
QTRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
QTRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 39.4 | Neutral |
QTRX's weekly RSI is 43 (neutral) and its Stochastic is 39 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
QTRX PE vs Healthcare Sector
QTRX has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over QTRX on trend strength, trading above more of its moving averages.
QTRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.07 | 6.8% below |
| 20 week MA | $3.22 | 11% below |
| 50 week MA | $4.24 | 33% below |
| 100 week MA | $5.37 | 47% below |
| 200 week MA | $11.9 | 76% below |
QTRX is in a downtrend: it's below all five of its weekly moving averages, and 76% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over QTRX on returns for 2026, with the stronger performance.
QTRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.5 | $45.9 | +95% |
| 2021 | $45.9 | $43.9 | -4.5% |
| 2022 | $43.9 | $12.9 | -71% |
| 2023 | $12.9 | $27.3 | +112% |
| 2024 | $27.3 | $11.1 | -60% |
| 2025 | $11.1 | $6.46 | -42% |
| 2026 YTD | $6.46 | $2.86 | -56% |
QTRX's yearly returns have swung widely, from +112% in 2023 to −71% in 2022. It's down 56% so far in 2026.